TuHURA Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HURA and other ETFs, options, and stocks.About HURA
TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. The firm’s lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors.
CEOJames A. Bianco
CEOJames A. Bianco
Employees19
Employees19
HeadquartersTampa, Florida
HeadquartersTampa, Florida
Founded2023
Founded2023
Employees19
Employees19
HURA Key Statistics
Market cap140.21M
Market cap140.21M
Price-Earnings ratio-0.25
Price-Earnings ratio-0.25
Dividend yield—
Dividend yield—
Average volume115.44K
Average volume115.44K
High today$3.36
High today$3.36
Low today$2.94
Low today$2.94
Open price$3.00
Open price$3.00
Volume157.62K
Volume157.62K
52 Week high$14.60
52 Week high$14.60
52 Week low$1.80
52 Week low$1.80
People also own
Based on the portfolios of people who own HURA. This list is generated using Robinhood data, and it’s not a recommendation.